drugset / Trial / NCT00558155

The Impact of Immunostimulating Nutrition on the Outcome of Surgery

NCT00558155

Phase 4 Completed 214 enrolled Jagiellonian University
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study was to assess the clinical effect of immunostimulatory enteral and parenteral nutrition in patients undergoing resection for gastrointestinal cancer. 205 subjects were randomly assigned into four study groups, standard and immunostimulating, enteral and parenteral. The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications following upper gastrointestinal surgery.

Timeline

Start
2001-06
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject BUNITROLOL Small molecule Other
Subject Dipeptiven Peptide Intravenous
Subject Omegaven Other / unclassified Intravenous
Subject peptisorb Unknown Other
Background Addamel Unknown Intravenous
Background Aminoplasmal Unknown Intravenous
Background Glucose Unknown Intravenous
Background Lipofundin MCT/ LCT Unknown Intravenous
Background Tracutil Unknown Intravenous